rethinkPeptides Search
Menu
Study breakdown

Thymosin Alpha-1 Shifts Hepatitis B Patient Immune Response From Th2 to Th1

evidence
The takeaway

Thymosin alpha-1 treatment shifted cytokine profiles from Th2-dominant (infection-permissive) to Th1-dominant (virus-fighting) in HBV patients with hepatitis B e-antigen, confirming its immune repolarization mechanism.

Key finding

Thymosin alpha-1 treatment shifted cytokine profiles from Th2-dominant (infection-permissive) to Th1-dominant (virus-fighting) in HBV patients with he

What the researchers found

Thymosin alpha-1 treatment shifted cytokine profiles from Th2-dominant (infection-permissive) to Th1-dominant (virus-fighting) in HBV patients with hepatitis B e-antigen, confirming its immune repolarization mechanism.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2010.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
Thymosin Alpha-1 Shifts Hepatitis B Patient Immune Response From Th2 to Th1
What was found?
Thymosin alpha-1 treatment shifted cytokine profiles from Th2-dominant (infection-permissive) to Th1-dominant (virus-fighting) in HBV patients with hepatitis B e-antigen, confirming its immune repolarization mechanism.

Read the original research

Effect of thymosin-α(1) on T-helper 1 cell and T-helper 2 cell cytokine synthesis in patients with hepatitis B virus e antigen-positive chronic hepatitis B.

The Journal of international medical research, 38(6), 2053-62

Citation

Jiang, Y-F; Ma, Z-H; Zhao, P-W; Pan, Y; Liu, Y-Y; Feng, J-Y; Niu, J-Q. (2010). Effect of thymosin-α(1) on T-helper 1 cell and T-helper 2 cell cytokine synthesis in patients with hepatitis B virus e antigen-positive chronic hepatitis B.. The Journal of international medical research, 38(6), 2053-62.